Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) EPS (Basic) (2021 - 2025)

Bioventus' EPS (Basic) history spans 5 years, with the latest figure at $0.22 for Q4 2025.

  • For Q4 2025, EPS (Basic) changed N/A year-over-year to $0.22; the TTM value through Dec 2025 reached $0.34, up 160.71%, while the annual FY2025 figure was $0.34, 160.71% up from the prior year.
  • EPS (Basic) reached $0.22 in Q4 2025 per BVS's latest filing, up from $0.05 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.22 in Q4 2025 to a low of -$1.76 in Q4 2022.
  • Average EPS (Basic) over 5 years is -$0.32, with a median of -$0.08 recorded in 2024.
  • Peak YoY movement for EPS (Basic): crashed 201797.82% in 2022, then surged 162.5% in 2025.
  • A 5-year view of EPS (Basic) shows it stood at -$0.0 in 2021, then plummeted by 201797.82% to -$1.11 in 2022, then increased by 6.31% to -$1.04 in 2023, then surged by 92.31% to -$0.08 in 2024, then soared by 375.0% to $0.22 in 2025.
  • Per Business Quant, the three most recent readings for BVS's EPS (Basic) are $0.22 (Q4 2025), $0.05 (Q3 2025), and $0.11 (Q2 2025).